{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:16Z","timestamp":1787004856418,"version":"build-2736575974"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1055\/a-1760-3843","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T18:40:15Z","timestamp":1658515215000},"page":"931-938","source":"Crossref","is-referenced-by-count":5,"title":["Fr\u00fche Implementierung der \u201eFantastic four\u201c bei Herzinsuffizienz mit reduzierter Ejektionsfraktion"],"prefix":"10.1055","volume":"147","author":[{"given":"Samira","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"T A McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/nejm199108013250501","article-title":"Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure","volume":"325","author":"Investigators*","year":"1991","journal-title":"New Engl J Medicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1161\/01.cir.0000038702.35084.d6","article-title":"Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial","volume":"106","author":"K C Wollert","year":"2002","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/nejmoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"J JV McMurray","year":"2019","journal-title":"New Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/nejmoa1409077","article-title":"Angiotensin \u2013 Neprilysin Inhibition versus Enalapril in Heart Failure","volume":"371","author":"J JV McMurray","year":"2014","journal-title":"New Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"B Pitt","year":"2003","journal-title":"New Engl J Med"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"M Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1007\/s00392-021-01867-2","article-title":"Timely and individualized heart failure management: need for implementation into the new guidelines","volume":"110","author":"A Abdin","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jchf.2021.06.011","article-title":"Drug Layering in Heart Failure: Phenotype-Guided Initiation","volume":"9","author":"G MC Rosano","year":"2021","journal-title":"JACCHeart failure"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? A\u00a0Redefinition of Evidence-Based Medicine","volume":"143","author":"J JV McMurray","year":"2021","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","article-title":"Heart failure drug treatment: the fantastic four","volume":"42","author":"J Bauersachs","year":"2021","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure","volume":"380","author":"E J Velazquez","year":"2019","journal-title":"New Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"M Vaduganathan","year":"2020","journal-title":"Lancet (London, England)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial","volume":"2","author":"J Butler","year":"2017","journal-title":"JAMA cardiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejim.2021.12.027","article-title":"Real world comparison of spironolactone and eplerenone in patients with heart failure","volume":"97","author":"P Pardo-Mart\u00ednez","year":"2022","journal-title":"Eur J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","author":"A A Voors","year":"2022","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"B Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0140-6736(18)32484-x","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"B P Halliday","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ejhf.1351","article-title":"Medication dosing for heart failure with reduced ejection fraction \u2013 opportunities and challenges","volume":"21","author":"C N Marti","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"K Swedberg","year":"2010","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"P W Armstrong","year":"2020","journal-title":"New Engl J Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1760-3843.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T21:15:40Z","timestamp":1661462140000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1760-3843"}},"subtitle":["Leitliniengerechte medikament\u00f6se Therapie \u2013 Ein praktischer Leitfaden"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":21,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1760-3843","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}